当前位置:首页 - 行情中心 - 百诚医药(301096) - 财务分析

百诚医药

(301096)

  

流通市值:45.11亿  总市值:59.52亿
流通股本:8278.72万   总股本:1.09亿

百诚医药(301096)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.06亿元,每股收益0.06元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益258547.14万元,未分配利润36499.97万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产394692.74万元,负债136145.61万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入509,883,681.59332,353,112.78128,727,480.49801,923,244.22
营业总成本508,846,004.57336,557,099.34164,765,613.68809,886,835.1
其他经营收益
营业利润7,650,161.613,685,713.16-27,913,185.92-34,393,587.84
利润总额7,965,059.063,900,486.09-27,784,050.64-36,060,972.55
净利润6,124,209.963,098,160.54-26,197,617.81-52,922,991.09
每股收益
其他综合收益-42,606.52-30,111.11-32,349.31-6,882.64
综合收益总额6,081,603.443,068,049.43-26,229,967.12-52,929,873.73
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,818,269,330.281,732,648,797.081,610,431,297.781,545,474,358.29
非流动资产:
非流动资产合计2,128,658,111.862,142,291,514.812,163,454,579.032,175,714,157.21
资产总计3,946,927,442.143,874,940,311.893,773,885,876.813,721,188,515.5
流动负债:
流动负债合计1,030,000,641.09951,870,447846,593,327.09769,379,232.56
非流动负债:
非流动负债合计331,455,413.33340,612,031.18374,132,732.56372,419,498.66
负债合计1,361,456,054.421,292,482,478.181,220,726,059.651,141,798,731.22
所有者权益(或股东权益):
归属于母公司股东权益合计2,585,471,387.722,582,457,833.712,553,159,817.162,579,389,784.28
股东权益合计2,585,471,387.722,582,457,833.712,553,159,817.162,579,389,784.28
负债和股东权益合计3,946,927,442.143,874,940,311.893,773,885,876.813,721,188,515.5
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计253,832,979.49211,529,707.21108,725,148.09652,039,793.93
经营活动现金流出小计433,618,596.71325,948,946.26178,755,029.29847,896,719.57
经营活动产生的现金流量净额-179,785,617.22-114,419,239.05-70,029,881.2-195,856,925.64
投资活动产生的现金流量:
投资活动现金流入小计308,533,773.48238,640,556.86128,032,273.42472,533,753.97
投资活动现金流出小计497,016,464.8374,813,468.47216,818,178.62937,071,213.72
投资活动产生的现金流量净额-188,482,691.32-136,172,911.61-88,785,905.2-464,537,459.75
筹资活动产生的现金流量:
筹资活动现金流入小计816,782,342.6510,000,000200,000,0001,253,720,662.98
筹资活动现金流出小计507,875,522.38276,094,193.7884,345,847.91955,630,611.49
筹资活动产生的现金流量净额308,906,820.22233,905,806.22115,654,152.09298,090,051.49
汇率变动对现金及现金等价物的影响312,756.01326,514.9-30,408.9112,965.02
现金及现金等价物净增加额-59,048,732.31-16,359,829.54-43,192,043.22-362,291,368.88
期末现金及现金等价物余额357,112,613.75399,801,516.52372,969,302.84416,161,346.06
补充资料:
现金及现金等价物的净增加额--16,359,829.54--362,291,368.88
最新报告期:2025-10-29
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
浙商证券胡隽扬0.460.640.902025-10-29
TOP↑